Agreement signedPublished 20 Feb 2025

AstraZeneca /
FibroGen International

AstraZeneca agrees to buy FibroGen International

Buy side: AstraZeneca
Buy sideAstraZeneca
Target: FibroGen International
TargetFibroGen International
Source · 20 Feb 2025Source-verified
Buy side: AstraZeneca
Buy sideAstraZeneca
Target: FibroGen International
TargetFibroGen International
01 / BuyerAstraZeneca
02 / SellerFibroGen China Anemia Holdings, Ltd.
03 / TargetFibroGen International
Source-verified
01

What happened

AstraZeneca agreed to acquire FibroGen International for approximately $160 million, according to a filing dated Feb. 20, 2025.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

AstraZeneca agrees to buy FibroGen International

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.